# Variant II Hemoglobin A1C Program

> Active: United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/variant-ii-hemoglobin-a1c-program-lcp>
- Manufacturer: [Bio-Rad](https://devicerts.com/manufacturers/bio-rad) (FDA registration: France)
- Name in the registry: VARIANT II HEMOGLOBIN A1C PROGRAM
- Device class: Class II (US FDA)
- FDA product code: LCP

## Registrations and authorizations

- **510(k)** · FDA 510(k) · United States · K984268 · decision 1998-12-17 · decision SESE · status: Active

## Recalls

- Z-1901-2010 ·  · terminated · initiated 2009-01-22: Sample test results for the first run appears to be correct but all subsequent results during that run were assigned incorrect barcode and tube position.
- Z-1902-2010 ·  · terminated · initiated 2009-01-22: Sample test results for the first run appears to be correct but all subsequent results during that run were assigned incorrect barcode and tube position.

## Identifiers

- 510(k) Number: K984268 [FDA 510(k)]
- FDA product code: LCP [FDA 510(k)]

## Classification

- Device class: Class II [FDA 510(k)]
- Regulation: 21 CFR Part 864.7470 [FDA 510(k)]
- Advisory committee: Hematology [FDA 510(k)]
- FDA decision: SESE [FDA 510(k)]

## Source and citation

- Cite as: Variant II Hemoglobin A1C Program, Bio-Rad. deviCERTS medical device catalogue. https://devicerts.com/devices/variant-ii-hemoglobin-a1c-program-lcp (data as of 2026-11-21).
- Data sources: [FDA 510(k)](https://open.fda.gov/apis/device/510k/), [FDA recalls](https://open.fda.gov/apis/device/recall/)
- Registry records last synced: 2026-10-22
- Statuses computed as of: 2026-11-21
- JSON: <https://devicerts.com/devices/variant-ii-hemoglobin-a1c-program-lcp.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/variant-ii-hemoglobin-a1c-program-lcp
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
